Idexx Laboratories (IDXX) Deferred Taxes (2009 - 2026)

Idexx Laboratories' Deferred Taxes history runs 18 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Deferred Taxes rose 251.82% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $141.1 million (up 898.56% YoY), while the FY2025 annual figure was $131.2 million, up 642.3% from the prior year.
• Deferred Taxes for Q1 2026 stood at $13.9 million, down from $31.5 million in the prior quarter.
• The five-year high for Deferred Taxes was $93.2 million in Q3 2025, with the low at -$33.6 million in Q4 2023.
• The 5-year median for Deferred Taxes is -$2.6 million (2024), against an average of $2.2 million.
• The sharpest annual moves came in 2022 and 2025: Deferred Taxes slumped 9186.81% in 2022, then jumped 1461.48% in 2025.
• Idexx Laboratories' Deferred Taxes stood at $1.8 million in 2022, then sank by 1938.74% to -$33.6 million in 2023, then jumped by 113.93% to $4.7 million in 2024, then jumped by 574.27% to $31.5 million in 2025, then tumbled by 55.95% to $13.9 million in 2026.
• Business Quant data shows IDXX's Deferred Taxes at $13.9 million in Q1 2026, $31.5 million in Q4 2025, and $93.2 million in Q3 2025.